[A case of community-acquired Listeria monocytogenes meningitis]

Tícia Kocsis1, Bálint Molnár2, Pál Ribiczey1

  • 11 Zala Vármegyei Szent Rafael Kórház, I. Belgyógyászati és Infektológiai Osztály Zalaegerszeg, Zrínyi M. u. 1., 8900 Magyarország.

Orvosi Hetilap
|September 11, 2023
PubMed

Insights

Listeria monocytogenes meningitis is rare but serious in older adults with risk factors. Prompt, targeted ampicillin therapy led to rapid recovery in a patient with hypertension and liver cirrhosis.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Internal Medicine

Background:

  • Listeria monocytogenes meningitis is uncommon in immunocompetent individuals.
  • Risk factors and central nervous system symptoms necessitate consideration of this diagnosis.
  • This case highlights diagnostic challenges in a patient with comorbidities.

Observation:

  • A 72-year-old man with hypertension and liver cirrhosis presented with fever, weakness, and neurological signs.
  • Initial empiric treatment with ceftriaxone and metronidazole was ineffective.
  • Cerebrospinal fluid analysis confirmed bacterial meningitis, but initial cultures were negative.

Findings:

  • Listeria monocytogenes was identified as the causative agent.
  • Targeted ampicillin therapy resulted in rapid resolution of fever and neurological symptoms.
  • The case underscores diagnostic pitfalls and the importance of appropriate antibiotic selection.

Implications:

  • Early and accurate diagnosis of Listeria monocytogenes meningitis is crucial for effective treatment.
  • Targeted antibiotic therapy, such as ampicillin, can lead to favorable outcomes.
  • This case emphasizes the need for vigilance in diagnosing rare infections in elderly patients with comorbidities.